Trial Profile

Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 21 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dulaglutide (Primary)
Indications Hyperglycaemia
Focus Therapeutic Use

Most Recent Events

17 Jan 2025 Status changed from recruiting to discontinued on 7 June 2024 at the Aim 2 part, due to new information about contraindications of the study drug in this population.
20 Sep 2024 Planned number of patients changed from 245 to 80.
05 Aug 2024 Planned End Date changed from 30 May 2026 to 1 May 2025.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com